Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting

Stock Information for BioLife Solutions Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BioLife Solutions Inc.

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Mustang Bio Announces Pricing of $4 Million Public Offering
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Avenue Therapeutics Announces Reverse Stock Split
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.